Available Technologies
# of Displayed Technologies: 1 / 1
Categories
.png)
Increasing the Yield of Respiratory Syncytial Virus Live Attenuated Vaccines
TS-000214 — Preventing RSV attachment protein cleavage in vaccine producing cells to increase yield.
A widespread economic problem of RSV vaccine candidates is their inefficient production. RSV vaccine candidates are produced in Vero, a cell line isolated from African green monkey kidney. Infectious disease experts at Nationwide Children’s Hospital have discovered RSV grown in Vero cells has …
- College:
- Inventors: Peeples, Mark; Corry, Jacqueline; Kwilas, Steve
- Licensing Officer: Zalucha, Ellen
